Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism
- PMID: 7550345
- DOI: 10.1038/ng1095-170
Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism
Abstract
Tay-Sachs and Sandhoff diseases are clinically similar neurodegenerative disorders. These two sphingolipidoses are characterized by a heritable absence of beta-hexosaminidase A resulting in defective GM2 ganglioside degradation. Through disruption of the Hexa and Hexb genes in embryonic stem cells, we have established mouse models corresponding to each disease. Unlike the two human disorders, the two mouse models show very different neurologic phenotypes. Although exhibiting biochemical and pathologic features of the disease, the Tay-Sachs model showed no neurological abnormalities. In contrast, the Sandhoff model was severely affected. The phenotypic difference between the two mouse models is the result of differences in the ganglioside degradation pathway between mice and humans.
Similar articles
-
Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.Endocrinology. 1998 Jul;139(7):3280-8. doi: 10.1210/endo.139.7.6117. Endocrinology. 1998. PMID: 9645704
-
Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.Hum Mol Genet. 1997 Oct;6(11):1879-85. doi: 10.1093/hmg/6.11.1879. Hum Mol Genet. 1997. PMID: 9302266
-
Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.Hum Mol Genet. 1996 Jan;5(1):1-14. doi: 10.1093/hmg/5.1.1. Hum Mol Genet. 1996. PMID: 8789434
-
[Recent advances in molecular genetics of GM2 gangliosidosis].Nihon Rinsho. 1995 Dec;53(12):2988-93. Nihon Rinsho. 1995. PMID: 8577047 Review. Japanese.
-
[Beta-N-acetyl-hexosaminidase--the enzyme of Tay-Sachs and Sandhoff diseases].Postepy Biochem. 1992;38(3):127-32. Postepy Biochem. 1992. PMID: 1461844 Review. Polish. No abstract available.
Cited by
-
Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma.Nat Commun. 2024 Oct 1;15(1):8506. doi: 10.1038/s41467-024-52888-0. Nat Commun. 2024. PMID: 39353936 Free PMC article.
-
Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials.Neurotherapeutics. 2024 Jul;21(4):e00443. doi: 10.1016/j.neurot.2024.e00443. Epub 2024 Sep 13. Neurotherapeutics. 2024. PMID: 39276676 Free PMC article. Review.
-
Characterization of a phenotypically severe animal model for human AB-Variant GM2 gangliosidosis.Front Mol Neurosci. 2023 Nov 30;16:1242814. doi: 10.3389/fnmol.2023.1242814. eCollection 2023. Front Mol Neurosci. 2023. PMID: 38098938 Free PMC article.
-
Lipid Structure Matters in Lysosomal Storage Disease.J Lipid Res. 2023 Dec;64(12):100476. doi: 10.1016/j.jlr.2023.100476. Epub 2023 Nov 14. J Lipid Res. 2023. PMID: 37972730 Free PMC article.
-
Targeting GM2 Ganglioside Accumulation in Dementia: Current Therapeutic Approaches and Future Directions.Curr Mol Med. 2024;24(11):1329-1345. doi: 10.2174/0115665240264547231017110613. Curr Mol Med. 2024. PMID: 37877564 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous